Safety
infection, pneumonia, leukopenia
PNEUMONIA, LEUKOPENIA, THROMBOCYTOPENIA, ADVERSE EFFECTS, ELEVATED TRIGLYCERIDES, INFECTION
Ruxolitinib’s main adverse effects include the potential for leukopenia, thrombocytopenia, elevated transaminases, elevated bilirubin, elevated triglycerides, infection (especially in pneumonia and urinary tract) (